CCR7 and urinary bladder cancer: Specifically, CXCL14 activates the CCR7/JAK2/STAT3 axis, leading to the upregulation of ERCC4 transcription, which promotes DNA damage repair in bladder cancer cells, thereby facilitating the development of chemoresistance.